Details of the Optogenetic System
| General Information of This Optogenetic System (OS) | ||||||
|---|---|---|---|---|---|---|
| OS ID |
OS00156
|
|||||
| OS Name |
Optogenetic LaG9
(OptoLaG9)
|
[1] | ||||
|
Photoreceptor (PR) |
||||||
| Cofactor | Flavin mononucleotide (FMN) | |||||
| Controlled Protein | Fusion protein | A anti-EGFP nanobody | ||||
| OS Application Information (1) | ||||||
|---|---|---|---|---|---|---|
| Mechanism of Action | J-alpha helix unfold | [ 1] | ||||
| Controlled Signal Pathway | Nanobody binds to respective binder | |||||
| Effect | Activation | |||||
| Application | Optogentic control protein binding using light switchable nanobodies | |||||
| Note | Open the door to developing light-switchable binders against a broad range of protein targets and may thus represent a first step toward an important class of photoswitchable biologics | |||||
| Light Information | Activation Wavelength | 450 nm | ||||
| Process | Reversible | |||||
| Deactivation Wavelength | Dark | |||||
| Activation Time | 2 min | |||||
| Deactivation Time | Minutes | |||||
| Light Intensity | 1 milliwatts per square centimeter | |||||
| Expression Information | Expression Method | Transfection | ||||
| Cell Lines | NIH 3T3 cells | |||||